FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Thread starter U.S. News
Start date Apr 30, 2026

U.S. News

Guest

Apr 30, 2026

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA's ⁠drug shortage ⁠list.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Prefix: N/A

Forum: USA News

Start date: Apr 30, 2026

Last reply date: Apr 30, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Apr 30, 2026

Replies: 0

Views: 11

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search